| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Legorreta Pablo G. | 20% | $3,372,819,557 | 103,112,796 | Legorreta G. Pablo | 16 May 2025 | |||
| MORGAN STANLEY | 9.2% | $1,394,427,274 | 38,907,011 | Morgan Stanley | 30 Jun 2025 | |||
| Capital International Investors | 7.7% | +16% | $1,265,287,125 | +$163,578,499 | 32,745,526 | +15% | Capital International Investors | 31 Dec 2025 |
| FMR LLC | 6.5% | -29% | $984,337,180 | -$400,247,331 | 27,900,714 | -29% | FMR LLC | 30 Sep 2025 |
| BlackRock, Inc. | 5.7% | $832,319,492 | 25,445,414 | BlackRock, Inc. | 31 Dec 2024 | |||
| Severgnini Achille G. | 5.7% | -17% | $978,612,513 | -$230,404,755 | 24,223,082 | -19% | Severgnini Achille G. | 06 Nov 2025 |
| GENERAL ATLANTIC, L.P. | 3.2% | $510,500,301 | 14,243,870 | General Atlantic, L.P. | 30 Jun 2025 | |||
| VANGUARD GROUP INC | 2.5% | $385,841,061 | 10,936,538 | The Vanguard Group | 30 Sep 2025 |
As of 31 Dec 2025, 528 institutional investors reported holding 356,815,826 shares of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX). This represents 84% of the company’s total 424,966,351 outstanding shares.
The largest institutional shareholders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | 13% | 55,274,069 | +25% | 0.13% | $2,135,790,095 |
| Capital International Investors | 7.3% | 31,104,309 | +14% | 0.19% | $1,201,870,500 |
| FMR LLC | 6.2% | 26,272,308 | -6.1% | 0.05% | $1,015,161,996 |
| BlackRock, Inc. | 6.2% | 26,188,692 | -0.05% | 0.02% | $1,011,931,068 |
| BAILLIE GIFFORD & CO | 4% | 17,008,768 | -2.1% | 0.55% | $657,218,795 |
| Swedbank AB | 2.8% | 11,942,143 | -2.1% | 0.45% | $461,444,406 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.8% | 11,740,594 | -1.9% | 0.69% | $453,656,552 |
| STATE STREET CORP | 2.5% | 10,649,641 | +3.7% | 0.01% | $411,502,128 |
| VANGUARD GROUP INC | 2.3% | 9,934,612 | -9.2% | 0.01% | $383,873,407 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 7,719,843 | +1.3% | 0.02% | $297,465,419 |
| Caledonia (Private) Investments Pty Ltd | 1.7% | 7,377,038 | -2.3% | 5.5% | $285,048,748 |
| CITADEL ADVISORS LLC | 1.2% | 5,273,865 | +1236% | 0.14% | $203,782,144 |
| VICTORY CAPITAL MANAGEMENT INC | 1.2% | 5,106,905 | +9.7% | 0.11% | $197,330,809 |
| JANE STREET GROUP, LLC | 1.2% | 4,947,409 | +57% | 0.23% | $191,167,884 |
| NORTHERN TRUST CORP | 0.94% | 4,003,322 | -1.8% | 0.02% | $154,688,363 |
| NORGES BANK | 0.8% | 3,414,165 | 0.01% | $131,923,336 | |
| Patient Capital Management, LLC | 0.78% | 3,333,675 | +6.9% | 5% | $128,813,194 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.78% | 3,313,265 | +0.95% | 0.07% | $128,024,560 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.73% | 3,118,865 | -0.35% | 0.03% | $120,512,944 |
| Legal & General Group Plc | 0.73% | 3,088,098 | +9.4% | 0.03% | $119,324,106 |
| NEW SOUTH CAPITAL MANAGEMENT INC | 0.69% | 2,928,778 | +0.36% | 5.2% | $113,167,982 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.69% | 2,913,398 | -3.7% | 0.02% | $112,573,699 |
| BANK OF AMERICA CORP /DE/ | 0.64% | 2,708,925 | +2.3% | 0.01% | $104,672,844 |
| Amundi | 0.63% | 2,679,379 | +29% | 0.03% | $103,531,205 |
| Regal Partners Ltd | 0.62% | 2,640,708 | +84% | 5.9% | $102,036,956 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 356,815,826 | $13,776,735,187 | +$1,037,516,861 | $38.64 | 528 |
| 2025 Q3 | 327,857,430 | $11,565,438,504 | -$513,190,953 | $35.28 | 484 |
| 2025 Q2 | 342,210,637 | $12,333,363,729 | +$949,776,240 | $36.03 | 452 |
| 2025 Q1 | 317,255,108 | $9,879,343,045 | -$34,196,805 | $31.13 | 444 |
| 2024 Q4 | 320,707,173 | $8,183,523,072 | +$144,649,409 | $25.51 | 414 |
| 2024 Q3 | 312,434,792 | $8,832,030,084 | -$70,655,781 | $28.29 | 391 |
| 2024 Q2 | 316,171,106 | $8,334,967,211 | +$126,311,822 | $26.37 | 373 |
| 2024 Q1 | 311,994,207 | $9,469,625,864 | +$68,283,642 | $30.37 | 375 |
| 2023 Q4 | 310,848,061 | $8,731,929,890 | +$90,598,401 | $28.09 | 359 |
| 2023 Q3 | 300,556,312 | $8,159,558,450 | -$95,718,367 | $27.14 | 312 |
| 2023 Q2 | 302,776,880 | $9,312,865,143 | +$35,406,560 | $30.74 | 321 |
| 2023 Q1 | 301,740,017 | $10,870,806,631 | +$87,185,612 | $36.03 | 331 |
| 2022 Q4 | 299,214,570 | $11,818,548,636 | +$83,591,490 | $39.52 | 332 |
| 2022 Q3 | 298,186,963 | $11,983,269,244 | +$263,400,168 | $40.18 | 311 |
| 2022 Q2 | 291,545,338 | $12,256,604,812 | +$918,924,477 | $42.04 | 281 |
| 2022 Q1 | 270,383,631 | $10,536,275,796 | +$82,755,109 | $38.96 | 272 |
| 2021 Q4 | 268,200,640 | $10,687,984,091 | +$139,946,049 | $39.85 | 254 |
| 2021 Q3 | 265,367,304 | $9,590,727,932 | +$538,289,516 | $36.14 | 226 |
| 2021 Q2 | 250,410,928 | $10,263,954,175 | +$118,347,007 | $40.99 | 229 |
| 2021 Q1 | 246,400,511 | $10,747,503,399 | +$874,104,377 | $43.62 | 208 |
| 2020 Q4 | 226,132,987 | $11,317,812,164 | +$1,961,711,795 | $50.05 | 188 |
| 2020 Q3 | 155,310,287 | $6,522,638,173 | +$367,540,942 | $42.07 | 129 |
| 2020 Q2 | 146,093,806 | $7,034,558,503 | +$7,034,558,867 | $48.55 | 119 |
| 2020 Q1 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q4 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q3 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q2 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q1 | 15 | $1,000 | $66.67 | 1 |